Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Medtronic Leads in Question Again - Medical Product Outsourcing

What are you searching for?

Sign in

Medtronic Leads in Question Again

Medtronic leads show high fracture rates with ICD therapy defibrillators.

By: Laura Sassano

A lead manufactured by Medtronic Inc. has a higher fracture rate when used with implantable cardiac resynchronization (ICD) therapy defibrillators compared with conventional ICDs. A study released May 5 at the Heart Rhythm Society’s annual meeting in San Francisco, Calif., showed that the fracture rate with the Sprint Fidelis lead was 2.4 percent with the advanced ICD, compared with 1 percent when used with a conventional ICD.

Medtronic’s Sprint Fidelis lead was recalled in 2007. The recall resulted in a $268 million legal settlement.

Medtronic is headquartered in Minneapolis, Minn.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Add Medical Product Outsourcing as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters